The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.

The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.

Taxanes, including docetaxel (DOCE), are severely neurotoxic, causing disabling peripheral neuropathy. Co-treatment with neuroprotective agents has been proposed to prevent or reverse this. Besides its hemopoietic effects, erythropoietin (EPO) has neuroprotective and neurotrophic properties and when...

Bibliografske podrobnosti
Main Authors:	Cervellini, I, Bello, E, Frapolli, R, Porretta-Serapiglia, C, Oggioni, N, Canta, A, Lombardi, R, Camozzi, F, Roglio, I, Melcangi, R, D'incalci, M, Lauria, G, Ghezzi, P, Cavaletti, G, Bianchi, R
Format:	Journal article
Jezik:	English
Izdano:	2010

Podobne knjige/članki

Docetaxel-induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model.
od: Roglio, I, et al.
Izdano: (2009)

Beneficial effects of PKF275-055, a novel, selective, orally bioavailable, long-acting dipeptidyl peptidase IV inhibitor in streptozotocin-induced diabetic peripheral neuropathy.
od: Bianchi, R, et al.
Izdano: (2012)

Experimental epothilone B neurotoxicity: results of in vitro and in vivo studies.
od: Chiorazzi, A, et al.
Izdano: (2009)

Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies
od: Alessia Chiorazzi, et al.
Izdano: (2009-08-01)

Erythropoietin does not affect TNF and IL-6 production directly.
od: Cervellini, I, et al.
Izdano: (2013)

Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
od: Cervellini, I, et al.
Izdano: (2013)

Securing The Border: Examining The Interagency Border Control Management in Kedah and Perlis (S/O 13762)
od: Ahmad Apandi, Laila Suriya, et al.
Izdano: (2021)

N-Acetylcysteine Augments Surface Thiols and Differentially Modulates Cell Adhesion and Invasion in vitro and Metastatic Potential in vivo of B16F1 Melanoma
od: T. Laragione, et al.
Izdano: (2005-01-01)

Erythropoietin: still on the neuroprotection road
od: Nelvys Subirós, et al.
Izdano: (2012-05-01)

Target Identification of an Antimalarial Oxaborole Identifies AN13762 as an Alternative Chemotype for Targeting CPSF3 in Apicomplexan Parasites
od: Valeria Bellini, et al.
Izdano: (2020-12-01)

NEUROPROTECTIVE EFFECTS OF ERYTHROPOIETIN: OPPORTUNITIES, PROSPECTS AND REALITY (REVIEW)
od: I. Kladova, et al.
Izdano: (2014-09-01)

Erythropoietin (EPO) increases myelin gene expression in CG4 oligodendrocyte cells through the classical EPO receptor.
od: Cervellini, I, et al.
Izdano: (2013)

Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor
od: Carolina Castillo Hernández, et al.
Izdano: (2017-01-01)

The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.
od: Cesca, M, et al.
Izdano: (2009)

Endogenous erythropoietin as part of the cytokine network in the pathogenesis of experimental autoimmune encephalomyelitis.
od: Mengozzi, M, et al.
Izdano: (2008)

Erythropoietin Nanobots: Their Feasibility for the Controlled Release of Erythropoietin and Their Neuroprotective Bioequivalence in Central Nervous System Injury
od: Thi Huong Le, et al.
Izdano: (2022-03-01)

Neuroprotective effects of erythropoietin on rat retinas subjected to oligemia
od: Litia Alves de Carvalho, et al.
Izdano: (2018-04-01)

Neuroprotective mechanisms of erythropoietin in a rat stroke model
od: Juenemann Martin, et al.
Izdano: (2020-05-01)

Erythropoietin; a Novel Neuroprotective Agent for Ocular Disorders
od: Khalil Ghasemi Falavarjani, et al.
Izdano: (2011-01-01)

Erythropoietin (EPO) Increases Myelin Gene Expression in CG4 Oligodendrocyte Cells through the Classical EPO Receptor
od: Ilaria Cervellini, et al.
Izdano: (2013-06-01)

Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats
od: Annalisa Canta, et al.
Izdano: (2022-12-01)

Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease
od: Federica Rey, et al.
Izdano: (2021-01-01)

Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection
od: Bongki Cho, et al.
Izdano: (2022-02-01)

Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives
od: Alberto Zambelli, et al.
Izdano: (2023-01-01)

Neuroprotective effect of erythropoietin on anesthesia-induced neurotoxicity through the modulation of autophagy in
od: Bon-Wook Koo, et al.
Izdano: (2024-06-01)

Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms
od: M. Moransard, et al.
Izdano: (2017-10-01)

Endogenous neuroprotection during focal brain ischemia in rats: erythropoietin, ischemic pre- and postconditioning
od: A. A. Shmonin, et al.
Izdano: (2017-02-01)

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
od: Carlos M. Galmarini, et al.
Izdano: (2014-01-01)

Diffusion Tensor Imaging Changes Do Not Affect Long-Term Neurodevelopment following Early Erythropoietin among Extremely Preterm Infants in the Preterm Erythropoietin Neuroprotection Trial
od: Janessa B. Law, et al.
Izdano: (2021-10-01)

Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases
od: Federica Rey, et al.
Izdano: (2019-08-01)

Erythropoietin administration exerted neuroprotective effects against cardiac ischemia/reperfusion injury
od: Titikorn Chunchai, et al.
Izdano: (2022-01-01)

Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus
od: Jérémie Nadam, et al.
Izdano: (2007-02-01)

Erythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental stroke.
od: Mengozzi, M, et al.
Izdano: (2012)

Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial
od: Thomas R. Wood, et al.
Izdano: (2021-10-01)

Erythropoietin and sonic hedgehog mediate the neuroprotective effects of brain-derived neurotrophic factor against mitochondrial inhibition
od: Chia-Lin Wu, et al.
Izdano: (2010-10-01)

Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use
od: Serafina Perrone, et al.
Izdano: (2022-03-01)

Neuroprotective activity of a new erythropoietin formulation with increased penetration in the central nervous system
od: Etcheverrigaray Marina, et al.
Izdano: (2011-11-01)

Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia
od: Rhonda Souvenir, et al.
Izdano: (2011-10-01)

Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities.
od: Coleman, T, et al.
Izdano: (2006)

The Orphan Cytokine Receptor CRLF3 Emerged With the Origin of the Nervous System and Is a Neuroprotective Erythropoietin Receptor in Locusts
od: Nina Hahn, et al.
Izdano: (2019-10-01)